Literature DB >> 31587697

One year in review 2019: systemic sclerosis.

Simone Barsotti1, Martina Orlandi2, Veronica Codullo3, Marco Di Battista1, Gemma Lepri2, Alessandra Della Rossa4, Serena Guiducci2.   

Abstract

Systemic sclerosis (SSc) is a complex disorder characterised by the involvement of small arteries, microvessels and connective tissue, with deposition of fibrotic tissue and microvascular obliteration in the skin and internal organs. Due to the multifaceted nature of the disease, several articles are published in the medical literature every year, aimed at exploring different aspects of the pathogenesis, internal organ involvement and clinical aspects, and possible therapeutic approaches. In this article we have reviewed the literature on SSc of the past year, with the aim of identifying novel approaches that may help the treating physician in the clinical management of patients.

Entities:  

Mesh:

Year:  2019        PMID: 31587697

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  18 in total

Review 1.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

2.  The diagnostic challenge of patients with anti-U1-RNP antibodies.

Authors:  Ines Elhani; Kathy Khoy; Delphine Mariotte; Elisabeth Comby; Christian Marcelli; Brigitte Le Mauff; Alexandra Audemard-Verger; Jonathan Boutemy; Gwénola Maigné; Nicolas Martin Silva; Achille Aouba; Hubert de Boysson
Journal:  Rheumatol Int       Date:  2022-07-27       Impact factor: 3.580

Review 3.  Drugs in phase I and phase II clinical trials for systemic sclerosis.

Authors:  Melody P Chung; Lorinda Chung
Journal:  Expert Opin Investig Drugs       Date:  2020-03-25       Impact factor: 6.206

4.  Self-management interventions in systemic sclerosis: A systematic review.

Authors:  Robyn K Wojeck; Donald E Bailey; Tamara J Somers; Mitchell R Knisely
Journal:  Res Nurs Health       Date:  2021-03-02       Impact factor: 2.228

5.  Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.

Authors:  Irene Soffritti; Maria D'Accolti; Gloria Ravegnini; Maria-Cristina Arcangeletti; Clara Maccari; Flora De Conto; Adriana Calderaro; Elisabetta Caselli
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

6.  Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.

Authors:  Shobana Sankar; Mirette Habib; Sara Jaafar; Vivek Nagaraja; David Roofeh; Amber Young; Suiyuan Huang; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2021-03-10       Impact factor: 4.862

7.  Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy).

Authors:  Alessio Coi; Simone Barsotti; Michele Santoro; Fabio Almerigogna; Elena Bargagli; Marzia Caproni; Giacomo Emmi; Bruno Frediani; Serena Guiducci; Marco Matucci Cerinic; Marta Mosca; Paola Parronchi; Renato Prediletto; Enrico Selvi; Gabriele Simonini; Antonio Gaetano Tavoni; Fabrizio Bianchi; Anna Pierini
Journal:  Orphanet J Rare Dis       Date:  2021-02-17       Impact factor: 4.123

8.  Impact of Human Cytomegalovirus and Human Herpesvirus 6 Infection on the Expression of Factors Associated with Cell Fibrosis and Apoptosis: Clues for Implication in Systemic Sclerosis Development.

Authors:  Maria-Cristina Arcangeletti; Maria D'Accolti; Clara Maccari; Irene Soffritti; Flora De Conto; Carlo Chezzi; Adriana Calderaro; Clodoveo Ferri; Elisabetta Caselli
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

Review 9.  Old and new therapeutic strategies in systemic sclerosis (Review).

Authors:  Carmen Bobeica; Elena Niculet; Alin Laurentiu Tatu; Mihaela Craescu; Dan Vata; Laura Statescu; Alina Viorica Iancu; Carmina Liana Musat; Miruna Luminita Draganescu; Cristian Onisor; Mihaela Lungu; Silvia Fotea; Aurel Nechita; Bogdan Ioan Stefanescu; Laura Gheuca-Solovastru
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

10.  IFN-γ+ IL-17+ Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma.

Authors:  Xiaojing Xing; Anqi Li; Hong Tan; Yong Zhou
Journal:  J Cell Mol Med       Date:  2020-11-06       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.